These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 15641876)

  • 1. Remission rates in patients with anxiety disorders treated with paroxetine.
    Ballenger JC
    J Clin Psychiatry; 2004 Dec; 65(12):1696-707. PubMed ID: 15641876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
    Ammar G; Naja WJ; Pelissolo A
    Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B; Baldwin DS; Dolberg OT; Andersen HF; Stein DJ
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of generalized anxiety disorder: a review of the paroxetine clinical trials database.
    Rickels K; Rynn M; Iyengar M; Duff D
    J Clin Psychiatry; 2006 Jan; 67(1):41-7. PubMed ID: 16426087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study.
    Marchesi C; Cantoni A; Fontò S; Giannelli MR; Maggini C
    Pharmacopsychiatry; 2006 Mar; 39(2):60-5. PubMed ID: 16555166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
    Liebowitz MR; Gelenberg AJ; Munjack D
    Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
    Pollack MH; Zaninelli R; Goddard A; McCafferty JP; Bellew KM; Burnham DB; Iyengar MK
    J Clin Psychiatry; 2001 May; 62(5):350-7. PubMed ID: 11411817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder.
    Stocchi F; Nordera G; Jokinen RH; Lepola UM; Hewett K; Bryson H; Iyengar MK;
    J Clin Psychiatry; 2003 Mar; 64(3):250-8. PubMed ID: 12716265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.
    Liebowitz MR; Stein MB; Tancer M; Carpenter D; Oakes R; Pitts CD
    J Clin Psychiatry; 2002 Jan; 63(1):66-74. PubMed ID: 11838629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales.
    Sugarman MA; Loree AM; Baltes BB; Grekin ER; Kirsch I
    PLoS One; 2014; 9(8):e106337. PubMed ID: 25162656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of anxious disorders.
    Bourin M; Lambert O
    Hum Psychopharmacol; 2002 Dec; 17(8):383-400. PubMed ID: 12457374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxetine response and tolerability among ethnic minority patients with mood or anxiety disorders: a pooled analysis.
    Roy-Byrne PP; Perera P; Pitts CD; Christi JA
    J Clin Psychiatry; 2005 Oct; 66(10):1228-33. PubMed ID: 16259535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial.
    Misri S; Reebye P; Corral M; Milis L
    J Clin Psychiatry; 2004 Sep; 65(9):1236-41. PubMed ID: 15367052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
    Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
    Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis.
    Donovan MR; Glue P; Kolluri S; Emir B
    J Affect Disord; 2010 Jun; 123(1-3):9-16. PubMed ID: 19616306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.
    Rickels K; Zaninelli R; McCafferty J; Bellew K; Iyengar M; Sheehan D
    Am J Psychiatry; 2003 Apr; 160(4):749-56. PubMed ID: 12668365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine.
    Hollander E; Allen A; Steiner M; Wheadon DE; Oakes R; Burnham DB;
    J Clin Psychiatry; 2003 Sep; 64(9):1113-21. PubMed ID: 14628989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.
    Ball SG; Kuhn A; Wall D; Shekhar A; Goddard AW
    J Clin Psychiatry; 2005 Jan; 66(1):94-9. PubMed ID: 15669894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.